Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 1/2008

01.07.2008 | Short Communication

Primary peritoneal serous papillary carcinoma: clinical and laboratory characteristics

verfasst von: C. Iavazzo, G. Vorgias, M. Katsoulis, N. Kalinoglou, V. Dertimas, T. Akrivos

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Primary peritoneal papillary serous carcinoma (PPPSC) is an uncommon primary malignancy of the peritoneum. The aim of our study is to present the characteristics of such a rare entity through our case series.

Method

This is a retrospective study of nine cases of PPPSC who were treated between January 2002 and April 2007 in METAXA Memorial Cancer Hospital, Piraeus, Greece. Medical files and histopathological diagnosis of each patient were retrospectively studied.

Results

The median age of the patients was 63 years ranging from 44 up to 74 years. Clinically PPPSC presented with general abdominal discomfort in all of the patients. Three out of nine patients presented with constipation, 5/9 with distention, and 7/9 with ascites. All of the patients referred loss of appetite with weight gaining due to ascites. All the patients had pathological values of CA125 (over 35 U/ml) ranging from 125 up to 1,255 U/ml with median value 565 U/ml. Optimal debulking was possible in 3/9 of patients who were consequently treated with standard taxol-platin chemotherapy. Complete response was achieved in one woman. The median disease-free survival was 7 months and the median overall survival rate was 2.5 years.

Conclusion

PPPSC mimics ovarian papillary serous carcinoma regarding the clinical and laboratory characteristics but it has worse prognosis.
Literatur
1.
3.
Zurück zum Zitat Eltabbakh GH, Piver MS (1998) Extraovarian primary peritoneal carcinoma. Oncology 12:809–813 Eltabbakh GH, Piver MS (1998) Extraovarian primary peritoneal carcinoma. Oncology 12:809–813
4.
Zurück zum Zitat Eltabbakh GH, Piver MS, Natarajan N, Metlin CJ (1998) Epidemiologic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancer. Obstet Gynecol 1:254–259. doi:10.1016/S0029-7844(97) 00650-9 CrossRef Eltabbakh GH, Piver MS, Natarajan N, Metlin CJ (1998) Epidemiologic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancer. Obstet Gynecol 1:254–259. doi:10.​1016/​S0029-7844(97) 00650-9 CrossRef
6.
Zurück zum Zitat Swerdlow M (1959) Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary. Am J Obstet Gynecol 77:197–200PubMed Swerdlow M (1959) Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary. Am J Obstet Gynecol 77:197–200PubMed
8.
Zurück zum Zitat Bloss JD, Liao S-Y, Buller RE, Manetta A, Berman ML, McMeekin S et al (1993) Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol 50:347–351. doi:10.1006/gyno.1993.1223 PubMedCrossRef Bloss JD, Liao S-Y, Buller RE, Manetta A, Berman ML, McMeekin S et al (1993) Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol 50:347–351. doi:10.​1006/​gyno.​1993.​1223 PubMedCrossRef
9.
Zurück zum Zitat Jordan S et al (2007) Serous ovarian, fallopian tube, and primary peritoneal cancers: a comparative epidemiological analysis. Int J Cancer 122(7):1598–1603 Jordan S et al (2007) Serous ovarian, fallopian tube, and primary peritoneal cancers: a comparative epidemiological analysis. Int J Cancer 122(7):1598–1603
11.
Zurück zum Zitat Fromm GL, Gershenson DM, Silva EG (1990) Papillary serous carcinoma of the peritoneum. Obstet Gynecol 75:75–89 Fromm GL, Gershenson DM, Silva EG (1990) Papillary serous carcinoma of the peritoneum. Obstet Gynecol 75:75–89
12.
Zurück zum Zitat Hunter RW, Alexander ND, Soutter WP (1992) Meta-analysis of surgery in advanced ovarian carcinoma: is maximum cytoreductive surgery an independent determinant of prognosis? Am J Obstet Gynecol 166:504–511PubMed Hunter RW, Alexander ND, Soutter WP (1992) Meta-analysis of surgery in advanced ovarian carcinoma: is maximum cytoreductive surgery an independent determinant of prognosis? Am J Obstet Gynecol 166:504–511PubMed
13.
Zurück zum Zitat Menczer J (1992) Cytoreductive surgery in the treatment of advanced ovarian carcinoma. Some controversial aspects. Eur J Gynaecol Oncol 13:246–255PubMed Menczer J (1992) Cytoreductive surgery in the treatment of advanced ovarian carcinoma. Some controversial aspects. Eur J Gynaecol Oncol 13:246–255PubMed
15.
Zurück zum Zitat Dalrymple JC, Bannatyne P, Russell P et al (1989) Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases. Cancer 64:110–115. doi:10.1002/1097-0142(19890701)64:1≤110::AID-CNCR2820640120≥3.0.CO;2-5 Dalrymple JC, Bannatyne P, Russell P et al (1989) Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases. Cancer 64:110–115. doi:10.​1002/​1097-0142(19890701)64:1≤110::AID-CNCR2820640120≥3.0.CO;2-5
17.
Zurück zum Zitat Kowalski LD, Kanbour AI, Price FV et al (1997) A case-matched comparison of extraovarian versus primary ovarian adenocarcinoma. Cancer 79:1587–1594 Kowalski LD, Kanbour AI, Price FV et al (1997) A case-matched comparison of extraovarian versus primary ovarian adenocarcinoma. Cancer 79:1587–1594
18.
Zurück zum Zitat Ransom DT, Patel SR, Keeney GL, Malkasian GD, Edmonson JH (1990) Papillary serous carcinoma of the peritoneum. A review of 33 cases treated with platin-based chemotherapy. Cancer 66:1091–1094. doi:10.1002/1097-0142(19900915)66:6≤1091::AID-CNCR2820660602≥3.0.CO;2-F Ransom DT, Patel SR, Keeney GL, Malkasian GD, Edmonson JH (1990) Papillary serous carcinoma of the peritoneum. A review of 33 cases treated with platin-based chemotherapy. Cancer 66:1091–1094. doi:10.​1002/​1097-0142(19900915)66:6≤1091::AID-CNCR2820660602≥3.0.CO;2-F
19.
Zurück zum Zitat Piver MS, Eltabbakh GH, Hempling RE, Recio FO, Blumenson LE (1997) Two sequential studies for primary peritoneal carcinoma: induction with weekly cisplatin followed by either cisplatin-doxorubicincyclophosphamide or paclitaxel-cisplatin. Gynecol Oncol 67:141–146. doi:10.1006/gyno.1997.4843 PubMedCrossRef Piver MS, Eltabbakh GH, Hempling RE, Recio FO, Blumenson LE (1997) Two sequential studies for primary peritoneal carcinoma: induction with weekly cisplatin followed by either cisplatin-doxorubicincyclophosphamide or paclitaxel-cisplatin. Gynecol Oncol 67:141–146. doi:10.​1006/​gyno.​1997.​4843 PubMedCrossRef
20.
Zurück zum Zitat White CD (1993) Papillary intraperitoneal neoplasia resembling ovarian carcinoma after removal of benign ovaries. W V Med J 89:282–283PubMed White CD (1993) Papillary intraperitoneal neoplasia resembling ovarian carcinoma after removal of benign ovaries. W V Med J 89:282–283PubMed
21.
Zurück zum Zitat Dalrymple JC, Bannatyne P, Russel P, Solomon HJ, Tattersall MHN, Atkinson K et al (1989) Extraovarian peritoneal carcinoma. A clinicopathological study of 31 cases. Cancer 64:110–115. doi:10.1002/1097-0142(19890701)64:1≤110::AID-CNCR2820640120≥3.0.CO;2-5 Dalrymple JC, Bannatyne P, Russel P, Solomon HJ, Tattersall MHN, Atkinson K et al (1989) Extraovarian peritoneal carcinoma. A clinicopathological study of 31 cases. Cancer 64:110–115. doi:10.​1002/​1097-0142(19890701)64:1≤110::AID-CNCR2820640120≥3.0.CO;2-5
23.
Zurück zum Zitat Wick MR, Mills SE, Dehner LP, Bollinger DJ, Fechner RE (1989) Serous papillary carcinomas arising from the peritoneum and ovaries. A clinicopathologic and immunohistochemical comparison. Int J Gynecol Pathol 8:179–188. doi:10.1097/00004347-198909000-00001 PubMed Wick MR, Mills SE, Dehner LP, Bollinger DJ, Fechner RE (1989) Serous papillary carcinomas arising from the peritoneum and ovaries. A clinicopathologic and immunohistochemical comparison. Int J Gynecol Pathol 8:179–188. doi:10.​1097/​00004347-198909000-00001 PubMed
24.
Zurück zum Zitat Ransom DT, Patel SR, Keeney GL, Malkasian GD (1990) Papillary serous carcinoma of the peritoneum: a review of 33 cases treated with platin based chemotherapy. Cancer 66:1091–1094. doi:10.1002/1097-0142(19900915)66:6≤1091::AID-CNCR2820660602≥3.0.CO;2-F Ransom DT, Patel SR, Keeney GL, Malkasian GD (1990) Papillary serous carcinoma of the peritoneum: a review of 33 cases treated with platin based chemotherapy. Cancer 66:1091–1094. doi:10.​1002/​1097-0142(19900915)66:6≤1091::AID-CNCR2820660602≥3.0.CO;2-F
26.
Zurück zum Zitat Ben-Baruch G, Sivan E, Moran O, Rizel S, Menczer J, Seidman DS (1996) Primary peritoneal serous papillary carcinoma: a study of 25 cases and comparison with stage III–IV ovarian papillary serous carcinoma. Gynecol Oncol 60:393–396. doi:10.1006/gyno.1996.0060 PubMedCrossRef Ben-Baruch G, Sivan E, Moran O, Rizel S, Menczer J, Seidman DS (1996) Primary peritoneal serous papillary carcinoma: a study of 25 cases and comparison with stage III–IV ovarian papillary serous carcinoma. Gynecol Oncol 60:393–396. doi:10.​1006/​gyno.​1996.​0060 PubMedCrossRef
27.
Metadaten
Titel
Primary peritoneal serous papillary carcinoma: clinical and laboratory characteristics
verfasst von
C. Iavazzo
G. Vorgias
M. Katsoulis
N. Kalinoglou
V. Dertimas
T. Akrivos
Publikationsdatum
01.07.2008
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 1/2008
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-008-0678-4

Weitere Artikel der Ausgabe 1/2008

Archives of Gynecology and Obstetrics 1/2008 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.